| Title: |
Revised Recommendations for Restarting Teclistamab Following Dose Delays: Insights from the MajesTEC-1 Study on Clinical Safety, and from Simulated Pharmacokinetics and Cytokine Dynamics |
| Authors: |
Cardé, Natalia A. QuijanoAff1, IDs11523026012054_cor1; Niu, JinAff1; Guo, YueAff1; Zhou, JiaAff1; Qiu, XiaoAff1; Su, YamingAff2; Pérez-Ruixo, CarlosAff3; Vishwamitra, DeekshaAff1; Hodin, CarolineAff4; Stephenson, TaraAff1; Zuppa, AthenaAff1; Chastain, KatherineAff2; Kobos, RachelAff2; Samtani, Mahesh N.Aff2; Wang, WeirongAff1; Haddish-Berhane, NahorAff1; Van de Donk, Niels W. C. J.Aff5; Garfall, Alfred L.Aff6; Matous, Jeffrey V.Aff7 |
| Source: |
Targeted Oncology. :1-11 |
| Database: |
Springer Nature Journals |